Page last updated: 2024-10-23

aztreonam and Libman-Sacks Disease

aztreonam has been researched along with Libman-Sacks Disease in 1 studies

Aztreonam: A monocyclic beta-lactam antibiotic originally isolated from Chromobacterium violaceum. It is resistant to beta-lactamases and is used in gram-negative infections, especially of the meninges, bladder, and kidneys. It may cause a superinfection with gram-positive organisms.
aztreonam : A synthetic monocyclic beta-lactam antibiotic (monobactam), used primarily to treat infections caused by Gram-negative bacteria. It inhibits mucopeptide synthesis in the bacterial cell wall, thereby blocking peptidoglycan crosslinking.

Research Excerpts

ExcerptRelevanceReference
"A 31-year-old woman who had developed systemic lupus erythematosus at 17 years of age was admitted to the hospital for suspected cellulitis in the lower extremities."1.38Recurrent Helicobacter cinaedi cellulitis and bacteremia in a patient with systemic lupus erythematosus. ( Asahara, M; Asako, K; Kawakami, S; Kikuchi, H; Koshio, O; Ono, Y; Tansho, S; Ubagai, T; Ueda, T, 2012)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kikuchi, H1
Asako, K1
Tansho, S1
Ueda, T1
Koshio, O1
Ubagai, T1
Asahara, M1
Kawakami, S1
Ono, Y1

Other Studies

1 other study available for aztreonam and Libman-Sacks Disease

ArticleYear
Recurrent Helicobacter cinaedi cellulitis and bacteremia in a patient with systemic lupus erythematosus.
    Internal medicine (Tokyo, Japan), 2012, Volume: 51, Issue:22

    Topics: Adult; Anti-Bacterial Agents; Aztreonam; Bacteremia; Cellulitis; Communicable Diseases, Emerging; Fe

2012